Cultured CD4 + cells were washed in cold PBS with 2% FCS and 0.1% sodium azide and then stained with fluorescein isothiocyanate (FITC)- or PE-labeled antibody, anti-CD25, anti-CD45RO, anti-CD62L (BD ...

Tiziana Life Sciences Ltd., which is developing the intranasal fully human anti-CD3 monoclonal antibody foralumab for neurological indications, has reported results from studies using a nasal anti-CD3 ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of ...

目前全球已有两款BCMA/cd3双抗获批上市，分别为强生的Tecvayli（teclistamab）和辉瑞的Elrexfio（elranatamab）。 安进已经终止 ...